Last reviewed · How we verify
NCT06107153
Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control
Phase 3 trial testing Insulin Glargine 100 UNT/ML Pen Injector [Lantus] in Type2diabetes in 243 participants. Completed in 1 November 2024.
1 November 2024
Quick facts
| Lead sponsor | University of Basrah |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 243 |
| Start date | 1 November 2023 |
| Primary completion | 1 November 2024 |
| Estimated completion | 1 November 2024 |
| Sites | 1 location across Iraq |
Drugs / interventions tested
- Insulin Glargine 100 UNT/ML Pen Injector [Lantus] — full drug profile →
- Saxagliptin 2.5 mg/ Metformin Hydrochloride extended release 1000 mg — full drug profile →
- Pioglitazone 30mg — full drug profile →
Conditions studied
- Type2diabetes — all drugs for Type2diabetes →
Sponsor
University of Basrah
Who can join
Adults 18 to 65, any sex, with Type2diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, we aim to explore the beneficial effect of early short-term (two weeks), self-titrated, basal-only insulin therapy on the degree of glycemic control over 1-year follow through a prospective cohort.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06107153
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Type2diabetes
Currently open trials in the same condition.
- NCT06345196 — Motivational Interviewing Applied to Individuals With Diabetes · NA · recruiting
- NCT06322212 — Type 2 Diabetes and Blood Brain Barrier Improvement · EARLY_PHASE1 · recruiting
- NCT06575478 — Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients · Phase 2 · recruiting
- NCT06469437 — The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM · NA · recruiting
- NCT06875193 — DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes · Phase 4 · recruiting
Other University of Basrah trials
Trials by the same sponsor.
- NCT07501598 — Effectiveness of Sacral Massage on Labor Pain, Depression, Stress, and Anxiety · NA · not yet recruiting
- NCT07346677 — Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06107153 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Basrah
- Last refreshed: 30 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06107153.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing